activity of UCH-L1, this form of PD was proposed to result from a partial loss of UCH-L1 hydrolytic function. However, several pieces of evidence suggest that simple loss of hydrolytic function does not completely explain the PD phenotype in this family. First, the mutation residues that are not conserved between human and This activity is presumed to be critical for cytoplasmic other mammals (horse, mouse, and rat have Ala at posiprotein degradation, recycling free ubiquitin by cleaving tion 18) suggests that residue 18 is not involved in the ubiquitylated peptides that are the products of the pronormal "biological" activity of UCH-L1 and suggests the teasomal degradation of polyubiquitylated proteins existence of a distinct pathological UCH-L1 activity. We (Larsen et al., 1996, 1998) . The importance of the cytoset out to compare the properties of the high-and plasmic protein degradation pathway in Parkinson's dislow-risk human polymorphic UCH-L1 variants, using ease (PD) is suggested by the fact that two gene prod-␣-synuclein as a model substrate. In doing so, we disucts that are linked to familial PD are sensitive to or covered a novel ubiquitin-ubiquitin ligase activity of involved in this pathway: ␣-synuclein forms potentially UCH-L1 that may also be important in PD pathogenesis. pathogenic aggregates (protofibrils) when its concentra- brain using a standard method (Hell and Jahn, 1998).
coimmunoprecipitated from the synaptic vesicle fraction using a UCH-L1 antibody (Chemicon, pig polyclonal, Figure 2B ). In a separate experiment, UCH-L1 was isolated from rat brain lysate using an anion exchange column. A small fraction of the total ␣-synuclein coeluted with UCH-L1. Fractions containing both UCH-L1 and ␣-synuclein were treated with a UCH-L1 antibody (Chemicon, rabbit polyclonal), an ␣-synuclein antibody (Transduction Lab), or buffer (as a control), and the antibody complexes were precipitated. The precipitated complexes were dissociated and analyzed. The immunoprecipitation with UCH-L1 antibody revealed ␣-synuclein monomer and a ‫43ف‬ kDa species that was immunoreactive to both ␣-synuclein ( Figure 2C , eluent fractions) and ubiquitin (data not shown) antibodies. The MW of this species is consistent with diubiquitylated ␣-synuclein (see below). The fact that UCH-L1 coimmunoprecipitates with free and ubiquitylated ␣-synuclein suggests that either one may be a substrate of UCH-L1. This possibility contrasts with expectations based on the optimal in vitro substrates, which are ubiquitylated peptides and amino acids, not ubiquitylated proteins (Larsen et al., 1996 (Larsen et al., , 1998 .
Figure 1. A Structural Model for the UCH-L1-Ubiquitin Complex Does Not Explain the Protective Effect of the S18Y Polymorphism
The sequence of UCH-L1 is shown, mapped onto the determined fold ( Figure 3B ), but cotransfection with S18Y had little, ␣-synuclein-containing conjugate was a ‫43ف‬ kDa speif any effect (Յ50% increase). In every case, treatment cies, probably the diubiquitylated species (see asterisk, of the UCH-L1-transfected cells with lactacystin added Figure 4A ). Addition of UCH-L3 to the mixture of ubiquito the UCH-L1 effect, to produce comparable levels of tylated species had little effect, though a small amount ␣-synuclein as in the LC-treated untransfected cells.
Overexpression of UCH-L1 Variants in COS-7 structure of the highly homologous (52% identity) UCH-L3 com-

Cells Leads to a Buildup of ␣-Synuclein
of free ␣-synuclein was produced after a 2 hr incubation This result indicates that UCH-L1 transfection does not (data not shown). In contrast, UCH-L1 rapidly consumed increase ␣-synuclein expression and that accumulation the ␣-synuclein-ubiquitin conjugates, especially the 34 of ␣-synuclein resulted from inhibition of its degradation. kDa species (this species approximately comigrates Under similar conditions, overexpression of wt and with the coimmunoprecipitating species in Figure 2C ), treatment with a different proteasome inhibitor, MG132, producing a trace amount of free ␣-synuclein in the also synergistically increased the accumulation of process. Surprisingly, the major products of UCH-L1 ␣-synuclein-ubiquitin conjugates (see Supplemental treatment were high-molecular-weight ␣-synucleinData at http://www.cell.com/cgi/content/full/111/2/209/ ubiquitin conjugates, presumably formed by the net DC1). Accumulation of ␣-synuclein is unlikely to result addition of ubiquitin to mono-and diubiquitylated from the hydrolytic activity of UCH-L1, since (1) hy-␣-synuclein (free ␣-synuclein did not appear to be a drolase activity is expected to promote protein degradasubstrate for chain extension [see below]). The possibiltion by recycling free ubiquitin (Larsen et al., 1996 (Larsen et al., , 1998 , ity that UCH-L1, as opposed to a contaminating ligase, (2) the effects of I93M and wt were indistinguishable, was directly responsible for polyubiquitin chain extenwhereas I93M is a much less active hydrolase (Leroy et sion (red arrow in Figure 4A ), was strengthened by the al., 1998), and (3) S18Y, which has comparable hydrolytic observation that UCH-L3 treatment of the same crude activity as wt in vitro (see below), does not cause signifimixture did not result in chain extension. cant accumulation. Regardless of the molecular mechaThe possibility that UCH-L1 itself possesses "ubiquityl nism for the effect, it is consistent with a model in which ligase" activity is mechanistically reasonable ( Figure  S18Y reduces a toxic function of UCH-L1, since in-4B). Rather than reacting with water, the ubiquitylcreased accumulation of ␣-synuclein is likely to be toxic, enzyme thioester (or acyl enzyme), an intermediate in and the protective variant S18Y causes less accumulathe hydrolysis reaction, may be able to react directly tion than wt UCH-L1.
with a nucleophilic lysine of another ubiquitin to produce a ubiquitin-ubiquitin amide bond. In contrast to the wellcharacterized pathway of "biological" ubiquitylation (us-UCH-L1 Seems to Ubiquitylate ␣-Synucleining the E1, E2, and E3 ligases), which requires activation UCH-L1 Has Concentration-Dependent Ubiquityl reduced ability to form the acyl enzyme. Amino acid changes at residue 18 had a significant effect on ligase Ligase Activity That Is Reduced in the Case of S18Y, the "Protective" Variant activity, with wt and S18A having ‫-5ف‬fold greater activity than S18Y ( Figure 5C ). Moreover, the ratio of ligase activRecombinant human UCH-L1 proteins corresponding to the three characterized UCH-L1 genes (S18/I93 ϭ wildity to the total acyl enzyme formation decreased on dilution of wt and S18A, indicating that this activity is type [wt], S18/M93 ϭ I93M [Leroy et al. , 1998 ], and Y18/ I93 ϭ S18Y); a point mutant of wt containing the mouse/ not derived from the monomeric enzymes. This result can be explained by a model in which the ligase activity rat/horse amino acid, Ala, at position 18 (S18A); and human UCH-L3, the highly homologous (55% identical) is derived from a dimeric (and/or oligomeric) form of UCH-L1 that is increasingly populated at higher enzyme systemic variant, were expressed in E. coli and purified to apparent homogeneity (Larsen et al., 1996) The possibility of an indirect interaction between the wt (see Supplemental Data). The protective polymorphic polymorphism at position 18 and the I93M mutation is variant, S18Y, which did not show significant ligase acsuggested by the incomplete penetrance of the mutation tivity, was completely monomeric at 10 M, although ( Figure 7B) . Specifically, the father of the two effected dimer was detected at 28 M (see Supplemental Data). individuals (asterisk in Figure 7B ), who is the presumed As a complement to AU, higher oligomers were also carrier of I93M, did not develop PD. The genotype of detected by native gel electrophoresis; they were much the two characterized I93M-carrying individuals with remore prominent in the case of wt, as compared to S18Y spect to position 18 was not reported (Leroy et al.
, 1998). at concentration of 25 M (see Supplemental Data). Like
We set out to test the proposition that the incomplete wt, the S18A variant also contained a significant amount penetrance may result from a modifying effect of one of dimer at 13 M. Thus, the tendency for UCH-L1 to S18Y allele, and that the mechanism of modification dimerize correlated with the ligase activity. The I93M could be reduced ligase activity. protein, which showed reduced ligase activity as comThe 1:1 wt/I93M mixture, a possible model of the efpared to wt, also showed a reduced population of dimer fected heterozygotes (Leroy et al., 1998), showed a hyas compared to wt. drolase activity (blue bars in Figure 7C ) that was intermediate between that of the two enzymes, comparable to the sum of the monomeric hydrolases. The ligase activity The Dose-Dependent Effect of the Protective Allele Is Mirrored by the Effect of S18Y on of this mixture was also intermediate between wt and I93M (gray bar, Figure 7C ). The 1:1 S18Y/I93M mixture the In Vitro Ligase Activity of Wild-Type The suggested relationship between UCH-L1 ligase achad comparable hydrolytic activity (blue) but significantly reduced ligase activity (gray) relative to the wt/ tivity and enzyme dimerization prompted us to examine the in vitro enzymatic activities of 1:1 mixtures of UCH-I93M mixture. If ligase activity confers susceptibility, then the S18Y polymorphism could protect against I93M L1 variants. Three incubations were set up to mimic the common human genotypes with respect to the residue in trans. This effect may explain the incomplete penetrance of I93M. Furthermore, the nonadditivity of ligase 18 polymorphism: S18Y/S18Y, wt/S18Y, and wt/wt (Figure 7A) . Within this series, hydrolytic activity was conactivity is consistent with our proposal that ligase activity is a property of the dimer, and not the UCH-L1 stant (data not shown), but ligase activity increased, correlating to increasing risk (the analogous S18A/wt monomer. posttranslationally. Dimerization-dependent ligase acmodels is operative. We assume that, in order to avoid PD, ␣-synuclein levels are normally kept under the crititivity ( Figure 8A The mechanism by which UCH-L1 ligase activity pro-ATP-dependent process that requires E1, E2, and E3 ligases ( Figure 8B , to the left). UCH-L1 may be able to motes PD pathogenesis is not clear, but several models should be considered. Although the models discussed elaborate K63-linked polyubiquityl chains (note different pattern in Figure 8B ) on ␣-synuclein in a dimerizationbelow are, in principal, experimentally distinguishable, determination of the precise mechanism will be difficult dependent, ATP-independent process. The UCH-L1 ligase activity could produce an elevation of the cytosince it is likely that a combination of these (and other) 
